NIVF Multiplikator Forward P/S NewGenIvf
Streamlined supply chains for consumables in Asia minimize operational disruptions for NewGenIvf Group Limited. The forward price-to-sales ratio reflects current investor expectations, with the metric standing at 0.10. While a network of clinics and laboratories in Thailand and Cambodia ensures stability, legislative changes and regional demographic decline create certain risks for center occupancy rates.
NewGenIvf Corp (NIVF) - rincian metrik lan laporan keuangan
- rega saiki lan proyeksi nilai saham:
- data kapitalisasi pasar:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Rasio Total Utang marang Ekuitas NewGenIvf Group Limited|NIVF - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal NewGenIvf Group Limited|NIVF - Gunggung tanggungan utang perusahaan|Utang marang nilai buku NewGenIvf Corp|NIVF - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan NewGenIvf|Likuiditas cepet newgenivf.com
- data bathi bisnis lan rasio investasi:
NIVF - Bathi pungkasan|Bathi sing dikarepake NewGenIvf Group Limited|NIVF - Kapitalisasi marang bathi|Prakiraan rega marang bathi NewGenIvf Group Ltd|NIVF - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan NewGenIvf Corp|NIVF - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan NewGenIvf|NIVF - Bathi saben saham sajroning taun lumaku|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan newgenivf.com|NIVF - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep NewGenIvf Group Limited
- indikator dodolan lan pendapatan:
Pambiji fundamental:NewGenIvf (NIVF)
The forward P/S ratio determines the market value of a company relative to expected revenue, measuring the premium for growth potential and the degree of investment optimism. By analyzing the history of the forward P/S, an investor assesses the valuation justification for NewGenIvf Group (NIVF), whose expansion into Southeast Asia's reproductive medicine sector and implementation of innovations should ensure a steady inflow of capital and business scaling.
Pesaing wigati
Multiplikator Forward P/S HCA (HCA Healthcare)|Prakiraan rega marang pendapatan Tenet Healthcare Corp|Fresenius Medical Care Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Solventum Health|Encompass Health (EHC) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan UHS|DVA (DaVita) - Multiplikator Forward P/S|RadNet Inc (RDNT) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan OPCH (Option Care Health Inc)|Rasio rega marang prakiraan pendapatan SGRY (Surgery Partners Group)|Multiplikator Forward P/S PINC (Premier, Inc.)|EYE (nationalvision.com) - Rega mangsa ngarep marang pendapatan|PGNY: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan ARDT (Ardent Health)|SEM: Multiplikator Forward P/S|Prakiraan rega marang pendapatan Astrana Corp ASTH|Rasio rega marang prakiraan pendapatan Pediatrix Corp|USPH: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan The Pennant Group (PNTG)|ORGO - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Nutex Health Corp - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S Auna Corp AUNA|SBC - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan EOLS|CYH (Community Health Systems, Inc.) - Multiplikator forward rega marang pendapatan|BeautyHealth - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan MediWound Ltd|Rasio rega marang prakiraan pendapatan BTMD|Multiplikator Forward P/S JYNT|Rasio kapitalisasi marang dodolan sing dikarepake docgo.com|Rasio rega marang prakiraan pendapatan P3 Health Partners PIII|GANX - Multiplikator forward rega marang pendapatan|EUDA Health - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Basel Medical Group BMGL|CLGN (collplant.com) - Multiplikator forward rega marang pendapatan|CUPR: Rasio rega marang pendapatan sing dikarepake|CCM (Concord Medical) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep American Shared Hospital Services Inc AMS|Multiplikator Forward P/S MRM|avalon-globocare.com - Kapitalisasi marang prakiraan pendapatan|Rasio rega marang prakiraan pendapatan DIH Holding US, Inc. DHAI|XAGE: Kapitalisasi marang prakiraan pendapatan|ATI Physical Therapy Corp - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake CareMax Inc. CMAX|KDLY (Kindly MD Corp) - Multiplikator forward rega marang pendapatan|MODV (ModivCare Corp) - Rasio rega marang prakiraan pendapatan|NVOS (Novo Integrated Sciences) - Multiplikator Forward P/S|SunLink Health Systems, Inc - Rega mangsa ngarep marang pendapatan|Multiplikator forward rega marang pendapatan BACK (IMAC Holdings)
